S. Frustaci
- Oncology top 2%
- Vascular Tumors and Angiosarcomas 18
- Cancer Treatment and Pharmacology 16
- Colorectal Cancer Treatments and Studies 12
-
- Sarcoma Diagnosis and Treatment 28
- Rheumatology top 5%
-
- Cardiac tumors and thrombi 8
-
- Chemotherapy-induced organ toxicity mitigation 7
- Lymphoma Diagnosis and Treatment 6
-
- Colorectal and Anal Carcinomas 7
In The Last Decade
S. Frustaci
81 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Oncology 1.6k
- Pulmonary and Respiratory Medicine 1.4k
- Rheumatology 337
- Cardiology and Cardiovascular Medicine 432
- Pathology and Forensic Medicine 297
Countries citing papers authored by S. Frustaci
This map shows the geographic impact of S. Frustaci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Frustaci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Frustaci more than expected).
Fields of papers citing papers by S. Frustaci
This network shows the impact of papers produced by S. Frustaci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Frustaci. The network helps show where S. Frustaci may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S. Frustaci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 120 | |
| 2 | 2012 | 4 | |
| 3 | 2011 | 3 | |
| 4 | 2010 | 76 | |
| 5 | 2010 | 27 | |
| 6 | 2010 | 34 | |
| 7 | 2004 | 115 | |
| 8 | 2003 | 131 | |
| 9 | 2002 | 98 | |
| 10 | 1999 | 8 | |
| 11 | 1998 | 13 | |
| 12 | 1997 | 11 | |
| 13 | 1992 | 2 | |
| 14 | 1992 | 11 | |
| 15 | 1991 | 21 | |
| 16 | 1991 | 47 | |
| 17 | 1990 | 4 | |
| 18 | 1990 | 10 | |
| 19 | 1987 | 7 | |
| 20 | High dose metoclopramide in cisplatin treated patients | 1983 | 1 |
About S. Frustaci
S. Frustaci is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Dermatology, having authored 81 papers that have together received 2.4k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (28 papers), Vascular Tumors and Angiosarcomas (18 papers), Cancer Treatment and Pharmacology (16 papers), Colorectal Cancer Treatments and Studies (12 papers), Cardiac tumors and thrombi (8 papers), Chemotherapy-induced organ toxicity mitigation (7 papers), Colorectal and Anal Carcinomas (7 papers) and Lymphoma Diagnosis and Treatment (6 papers). The work is most often cited by research in Oncology (1.6k citations), Pulmonary and Respiratory Medicine (1.4k citations) and Rheumatology (337 citations). S. Frustaci has collaborated with scholars based in Italy, Ukraine and Spain. Frequent co-authors include Angela Buonadonna, Antonino De Paoli, F. Gherlinzoni, Alessandro Comandone, Piero Picci, Diego Serraino, Elena Barbieri, Gaetano Apice, Marco Bonetti and Patrizia Olmi. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer, Journal of Chemotherapy and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.